Related Experiment Video
Updated: Jan 17, 2026
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Mixed-Phenotype Acute Leukaemia: Bridging the Gap Between Myeloid and Lymphoid Lineages
Muhammad Zain Arshad1,2, Muhammad Hussain1,2, Muhammad Omair Riaz1,2
1Department of Immunology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan.
Insights
Mixed-phenotype acute leukaemia (MPAL) is most common in males in Pakistan, with B/Myeloid MPAL being the prevalent subtype. This study highlights an average diagnostic delay of five weeks for MPAL.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Mixed-phenotype acute leukaemia (MPAL) is a rare and complex haematological malignancy.
- Characterizing MPAL is crucial for accurate diagnosis and treatment.
- Previous studies on MPAL immunophenotypes in Pakistan are limited.
Purpose of the Study:
- To characterize mixed-phenotype acute leukaemia (MPAL) using flowcytometric immunophenotyping.
- To determine the prevalence and subtypes of MPAL in a Pakistani population.
- To analyze diagnostic delays and patient demographics associated with MPAL.
Main Methods:
- A descriptive, cross-sectional study was conducted involving 1,115 patients suspected of acute leukaemia.
- Flowcytometric immunophenotyping was performed on peripheral blood, bone marrow, or cerebrospinal fluid samples.
- Data analysis included frequency, percentages, mean ± SD, and Chi-square test for comparisons.
Main Results:
- Out of 875 acute leukaemia cases, 11 (1.25%) were diagnosed as MPAL.
- B/Myeloid MPAL was the most common subtype (63.6%), followed by T/Myeloid MPAL (27.3%).
- MPAL was more prevalent in males (81.8%) and had an average diagnostic delay of 5.5 weeks.
Conclusions:
- B/Myeloid MPAL is the predominant subtype in the Pakistani population studied.
- MPAL is more common in males and can occur across all age groups.
- An average diagnostic delay of approximately five weeks was observed for MPAL.
Objective:
To characterise mixed-phenotype acute leukaemia (MPAL) using flowcytometric immunophenotyping in a flow cytometric local population of Pakistan.
Study Design:
A descriptive, cross-sectional study. Place and Duration of the Study: Department of Immunology, Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan, from November 2021 to October 2023.
Methodology:
A total of 1,115 patients (728 males and 387 females) with peripheral blood, bone marrow, or cerebrospinal fluid samples referred for immunophenotyping due to suspected acute leukaemia were included in the study. Cells were stained with lineage-specific fluorochrome-labelled monoclonal antibodies. Acquisition of cell suspension was done on the BD FACS Canto II multi-parameter (flow cytometer), and analysis was done on the BD FACS Diva software. Qualitative variables (gender, diagnosis, or positivity of CD markers) were expressed as frequency and percentages, and quantitative variables (age) were expressed as mean ± SD. The Chi-square test was used to compare positivity in both male and female patients.
Results:
Among 875 patients with acute leukaemia, 11 cases (1.25%) were diagnosed as MPAL, with a mean age 32 ± 28 years. Of the MPAL cases 9 (81.8%) were males, and 2 (18.2%) were females (p = 0.25). The most common MPAL subtype was B-myeloid, found in 7 out of 11 cases (63.6%), followed by T-myeloid in 3 cases (27.3%) and B-T MPAL in 1 case (9.1%). The aberrant expression of a third lineage was present in 2 out of 11 cases, (18.2%), while 9 cases (81.8%) were biphenotypic, and 2 cases (18.2%) were bilineage. A fatal outcome occurred in 3 out of 11 cases (27.3%) and the average diagnostic delay was 5.5 weeks.
Conclusion:
In a local Pakistani population, B/Myeloid MPAL is the most prevalent immunophenotype, followed by T/Myeloid MPAL, with an average diagnostic delay of about five weeks. It is more common in males and can occur at any age, from infancy to old age.
Key Words:
Acute leukaemia of ambiguous lineage, Bilineage acute leukaemia, Biphenotypic acute leukaemia, Mixed-phenotype acute leukaemia.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
01:21Lineage Commitment